Inovio Pharmaceuticals (INO) Stock Price, Quote, News & History | Benzinga

SPY778.57+0.60%QQQ751.38+0.51%BTC/USD83,540.01+0.74%DIA516.21+0.89%GLD384.50+1.55%TLT77.97+0.12%

Inovio Pharmaceuticals Inc (INO) Stock Price, Quote, News & History

INONASDAQ

Trade with Public

Trade with Public

$1.15

0.065.5%

Last update: Oct 9, 7:41 PM

$1.15

0.05885.39%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$1.10

Close

$1.15

Volume / Avg.

2.89M / 3.79M

Day Range

$1.15 - $1.15

52 Wk Range

0.56 - 2.72

Market Cap

$112.70M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

47

Short Interest

22.33%

Days to Cover

7.59

Recent Inovio Pharmaceuticals Inc News

Nasdaq Surges Over 600 Points; Microsoft Shares Jump After Upbeat Q4 Results

US stocks rise with Nasdaq up 600 points, Dow up 0.69% and S&P 500 up 1.29%. Tech shares up 5%, communication services down 3.3%. Microsoft jumps 15% after strong earnings.

Avi Kapoor

Why Microsoft Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket

Microsoft (NASDAQ: MSFT) reported strong Q4 results, beating revenue and earnings estimates. Shares jumped 7.8% in pre-market trading.

Avi Kapoor

Inovio Stock Falls 21% After Hours: Here's What's Going On

Inovio stock fell after hours after pricing a $20 million public offering of common stock and warrants.

Tanya Rawat

What's Going On With Inovio Pharmaceuticals Stock On Tuesday?

Inovio prices a $17.5 million share offering, narrows losses, cuts expenses, and advances INO-3107 under FDA review.

Vandana Singh

What's Behind The Drop In Inovio Pharmaceuticals Stock Today?

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) shares are tumbling Thursday after the company announced the pricing of a proposed public offering.

Alex Perry

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-80.58M

Investing Cash Flow (TTM)

17.59M

Financing Cash Flow (TTM)

70.17M

Free Cash Flow (TTM)

-80.78M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

7.17M

Analyst Trends and Forecast

1

Jun

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$90.24M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

25.67

Earnings Yield % (TTM)

-94.93%

Earnings Yield % (FWD)

-19.35%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.04

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$31.53M

Debt to Equity

1.83

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-